Boston Scientific Corporation vs Equinor ASA — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Equinor ASA trades at $40.47 (market cap $97.58B). The key difference: Equinor ASA is the larger of the two by market cap, and Equinor ASA pays a 3.81% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | EQNR | |
|---|---|---|
Market Cap | $74.19B | $97.58B |
Sector | Health | Energy |
52-Week High | $108.14 | $42.40 |
52-Week Low | $42.63 | $22.41 |
Enterprise Value | $86.27B | $106.28B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →